반응식
Cl[C:2]1[CH:11]=[CH:10][C:9]2[C:8]([C:12]([NH:14][CH2:15][CH2:16][CH:17]3[CH2:22][CH2:21][CH2:20][CH2:19][CH2:18]3)=[O:13])=[C:7]([Cl:23])[CH:6]=[CH:5][C:4]=2[N:3]=1.Cl.[C:25]([CH:27]1[CH2:32][CH2:31][NH:30][CH2:29][CH2:28]1)#[N:26]>>[Cl:23][C:7]1[CH:6]=[CH:5][C:4]2[N:3]=[C:2]([N:30]3[CH2:31][CH2:32][CH:27]([C:25]#[N:26])[CH2:28][CH2:29]3)[CH:11]=[CH:10][C:9]=2[C:8]=1[C:12]([NH:14][CH2:15][CH2:16][CH:17]1[CH2:22][CH2:21][CH2:20][CH2:19][CH2:18]1)=[O:13]참가 물질
3
실험 절차
Prepared according to the method of example 51, using 2,6-dichloro-N-(cyclohexylethyl)-5-quinolinecarboxamide (Example 94 (d)) (0.35 g), and 4-cyanopiperidine hydrochloride (0.25 g) to afford the title compound (0.12 g).
후처리
- customPrepared
출처 및 근거
- ORD 기록
- ord-80495ad9d07746538a204bcee4b5025c
- 출처 데이터셋
- uspto-grants-2008_08
- 특허 번호
- US07408065B2
연결된 노트
불러오는 중…